277 related articles for article (PubMed ID: 33985534)
1. High copy number variations, particular transcription factors, and low immunity contribute to the stemness of prostate cancer cells.
Dai Z; Liu P
J Transl Med; 2021 May; 19(1):206. PubMed ID: 33985534
[TBL] [Abstract][Full Text] [Related]
2. A novel tumor purity and immune infiltration-related model for predicting distant metastasis-free survival in prostate cancer.
Su Q; Zhu Y; He B; Dai B; Mu W; Tian J
Eur J Med Res; 2023 Nov; 28(1):545. PubMed ID: 38017548
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer.
Zhang T; Li J; Dai J; Yuan F; Yuan G; Chen H; Zhu D; Mao X; Qin L; Liu N; Yang M
Cancer Genet; 2023 Aug; 276-277():48-59. PubMed ID: 37487324
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Bulk RNA Sequencing Data Reveals Novel Transcription Factors Associated With Immune Infiltration Among Multiple Cancers.
Liu L; Zhao Q; Cheng C; Yi J; Sun H; Wang Q; Quan W; Xue Y; Sun L; Cong X; Zhang Y
Front Immunol; 2021; 12():644350. PubMed ID: 34489925
[TBL] [Abstract][Full Text] [Related]
5. Stemness Related Genes Revealed by Network Analysis Associated With Tumor Immune Microenvironment and the Clinical Outcome in Lung Adenocarcinoma.
Zeng H; Ji J; Song X; Huang Y; Li H; Huang J; Ma X
Front Genet; 2020; 11():549213. PubMed ID: 33193623
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer.
Zhu W; Wu J; Huang J; Xiao D; Li F; Wu C; Li X; Zeng H; Zheng J; Lai W; Wen X
Front Immunol; 2023; 14():1122670. PubMed ID: 37122696
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein receptor promotes crosstalk between cell stemness and tumor immune microenvironment in breast cancer: a large data-based multi-omics study.
Yuan Q; Lu X; Guo H; Sun J; Yang M; Liu Q; Tong M
J Transl Med; 2023 Nov; 21(1):871. PubMed ID: 38037058
[TBL] [Abstract][Full Text] [Related]
8. An Integrative Multi-Omics Analysis Based on Nomogram for Predicting Prostate Cancer Bone Metastasis Incidence.
Zhao J; Wang R; Sun X; Huang K; Jin J; Lan L; Jian Y; Xu Z; Wu H; Wang S; Wang J
Genet Res (Camb); 2022; 2022():8213723. PubMed ID: 36245556
[TBL] [Abstract][Full Text] [Related]
9. Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency.
Yeh HY; Cheng SW; Lin YC; Yeh CY; Lin SF; Soo VW
BMC Med Genomics; 2009 Dec; 2():70. PubMed ID: 20025723
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma.
Ye Z; Zheng M; Zeng Y; Wei S; Wang Y; Lin Z; Shu C; Xie Y; Zheng Q; Chen L
Front Genet; 2020; 11():595477. PubMed ID: 33362856
[TBL] [Abstract][Full Text] [Related]
11. Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram.
Rui X; Shao S; Wang L; Leng J
BMC Cancer; 2019 Dec; 19(1):1179. PubMed ID: 31795990
[TBL] [Abstract][Full Text] [Related]
12. Identification of castration-resistant prostate cancer-related hub genes using weighted gene co-expression network analysis.
Cheng Y; Li L; Qin Z; Li X; Qi F
J Cell Mol Med; 2020 Jul; 24(14):8006-8017. PubMed ID: 32485038
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data.
Hua Y; Gao L; Li X
Pathol Oncol Res; 2021; 27():1609789. PubMed ID: 34408553
[No Abstract] [Full Text] [Related]
14. Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index.
Bai KH; He SY; Shu LL; Wang WD; Lin SY; Zhang QY; Li L; Cheng L; Dai YJ
Cancer Med; 2020 Jun; 9(12):4290-4298. PubMed ID: 32311840
[TBL] [Abstract][Full Text] [Related]
15. BRCA-Pathway: a structural integration and visualization system of TCGA breast cancer data on KEGG pathways.
Kim I; Choi S; Kim S
BMC Bioinformatics; 2018 Feb; 19(Suppl 1):42. PubMed ID: 29504910
[TBL] [Abstract][Full Text] [Related]
16. Construction of Metastasis-Specific Regulation Network in Ovarian Cancer Based on Prognostic Stemness-Related Signatures.
Wang W; Guo H; Wu S; Xian S; Zhang W; Zhang R; Chen Z; Su K; Zhang Y; Zhu Y; Chu D; Zhao M; Tang Z; Zheng C; Huang Z; Ma Q; Guo R
Reprod Sci; 2023 Sep; 30(9):2634-2654. PubMed ID: 36940084
[TBL] [Abstract][Full Text] [Related]
17. Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer.
Luo C; Chen J; Chen L
Int Immunopharmacol; 2020 Sep; 86():106709. PubMed ID: 32593155
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis Reveals USP45 as a Novel Putative Oncogene in Pan-Cancer.
Li K; Wang Q; Bian H; Chen Z; He H; Zhao X; Gong P
Front Mol Biosci; 2022; 9():886904. PubMed ID: 35836933
[No Abstract] [Full Text] [Related]
19. Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune Microenvironment.
Ohandjo AQ; Liu Z; Dammer EB; Dill CD; Griffen TL; Carey KM; Hinton DE; Meller R; Lillard JW
Sci Rep; 2019 Oct; 9(1):14963. PubMed ID: 31628349
[TBL] [Abstract][Full Text] [Related]
20. Immune-related biomarker risk score predicts prognosis in prostate cancer.
Liu Z; Zhong J; Cai C; Lu J; Wu W; Zeng G
Aging (Albany NY); 2020 Nov; 12(22):22776-22793. PubMed ID: 33197890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
